RAPT Therapeutics
RAPT
RAPT was delisted on the 2nd of March, 2026.
94 hedge funds and large institutions have $59.9M invested in RAPT Therapeutics in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 19 closing their positions.
2,300% more call options, than puts
Call options by funds: $120K | Put options by funds: $5K
12% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 26
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.72% less ownership
Funds ownership: 11.39% → 10.67% (-0.72%)
9% less funds holding
Funds holding: 103 → 94 (-9)
38% less capital invested
Capital invested by funds: $97M → $59.9M (-$37.1M)
47% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PFCS
Pale Fire Capital SE
Prague,
Czech Republic
|
+$1.25M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$948K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$528K |
| 4 |
D.E. Shaw & Co
New York
|
+$356K |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
+$295K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$2.2M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.64M |
| 3 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$1.52M |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$606K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$460K |
RAPT Hedge Fund Activity: Q3 2024 in Review
94 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in RAPT Therapeutics (RAPT) for Q3 2024, worth a combined $59.9M — down 38% from $97M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of RAPT and 10 opened new positions — a net loss of 9 holders — while 26 trimmed existing stakes and 29 added.
The largest buyer was Pale Fire Capital SE, adding an estimated $1.25M. The largest seller was Morgan Stanley, cutting an estimated $2.2M.
- 94 institutional investors held RAPT Therapeutics (RAPT) as of Q3 2024, down from 103 in Q2 2024.
- Funds reported $59.9M of RAPT Therapeutics stock for Q3 2024, down 38% quarter-over-quarter.
- 10 funds opened new RAPT Therapeutics positions in Q3 2024 and 19 closed out, a net change of -9 holders.
- The largest RAPT Therapeutics buyer in Q3 2024 was Pale Fire Capital SE, an estimated $1.25M added.
- The largest RAPT Therapeutics seller in Q3 2024 was Morgan Stanley, an estimated $2.2M sold.
Based on aggregated 13F filings for Q3 2024.